Product Description

The new anticoagulants were first used for thrombosis prevention after orthopedic surgery, including total hip and knee replacement, and its efficacy and safety have been reported to be no worse than low molecular weight heparin. Nowadays, new anticoagulants are gradually widely used in the treatment of lower limb venous thrombosis and pulmonary embolism. It is mentioned in the latest diagnosis and treatment guidelines of acute pulmonary embolism formulated by ESC in 2014 that new anticoagulants can be used as an emerging anticoagulant to replace traditional anticoagulant therapy, and will be gradually promoted in atrial fibrillation, acute coronary syndrome and other cardiovascular diseases with high incidence.

Rivaroxaban, which has been approved for the prevention of venous thrombosis (VTE) in adult patients undergoing hip or knee replacement surgery; And treatment of deep vein thrombosis (DVT) in adults, reducing the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT. Atrial fibrillation is a common arrhythmia that affects up to 10% of people over the age of 75. Blood in patients with atrial fibrillation is easy to form thrombus due to blood stasis in the heart chamber, and thrombus shedding can lead to stroke. Rivaroxaban, has been approved and is recommended for adult patients with nonvalvular atrial fibrillation to reduce the risk of stroke and systemic embolism.

Company Information
Hebei Lingding Biotechnology Co., Ltd. is a professional business company ,that include pharmaceutical raw materials, pharmaceutical intermediates,and other more than 1000 products of the enterprise,  The registered capital is 3 million yuan, it is a collection of scientific research, production and sales in one of the enterprises.
Since its establishment, the company has always adhered to the core concept of "focus on products, attentive service", adhere to the business purpose of "innovation, professional, win-win", to provide customers with a full range of meticulous and thoughtful services. We will adhere to the customer's serious and responsible attitude, comply with the standardized operation procedures, with efficient execution to complete customer needs.
The company's products are sold all over the world, mainly exported to the United States, Europe, Southeast Asia, Australia, the Middle East and South Africa and other countries.The company has a strong scientific research and technical team, can provide customers with high quality products and a full range of services. We will provide first-class products and better service to face the needs of customers, to meet the challenges of the market.  Welcome domestic and foreign customers to negotiate.